Table 1 Overview and names of the core simulation scenariosa
From: Controlling false positives in the mapping of epistatic QTL
Epistasis form | 2.5% hepi2 | 5.0% hepi2 | 7.5% hepi2 | 10.0% hepi2 | 12.5% hepi2 |
|---|---|---|---|---|---|
Complementary | Com2.5% (17.6) | Com5.0% (35.0) | Com7.5% (52.5) | — | — |
Dominant | Dom2.5% (6.8) | Dom5.0% (15.6) | Dom7.5% (25.0) | — | — |
Recessive | Rec2.5% (10.0) | Rec5.0% (20.2) | Rec7.5% (30.5) | — | — |
Inhibitory | Inh2.5% (10.9) | Inh5.0% (21.7) | Inh7.5% (32.5) | — | — |
Duplicate | Dup2.5% (4.2) | Dup5.0% (8.3) | Dup7.5% (12.5) | — | — |
Interaction only | Int2.5% (2.5) | Int5.0% (5.0) | Int7.5% (7.5) | Int10.0% (10.0) | Int12.5% (12.5) |
